5WF5
Agonist bound human A2a adenosine receptor with D52N mutation at 2.60 A resolution
5WF5 の概要
| エントリーDOI | 10.2210/pdb5wf5/pdb |
| 分子名称 | Human A2a adenosine receptor T4L chimera, 6-(2,2-diphenylethylamino)-9-[(2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxy-oxolan-2-yl]-N-[2-[(1-pyridin-2-ylpiperidin-4-yl)carbamoylamino]ethyl]purine-2-carboxamide, (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate, ... (4 entities in total) |
| 機能のキーワード | human a2a adenosine receptor, d52n, gpcr-t4l chimera, membrane protein, lcp, agonist, uk432097, activation microswitch, allosteric na-site mutant, gpcr signaling |
| 由来する生物種 | Homo sapiens (Human) 詳細 |
| 細胞内の位置 | Cell membrane; Multi-pass membrane protein: P29274 |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 58046.03 |
| 構造登録者 | White, K.L.,Eddy, M.T.,Gao, Z.,Han, G.W.,Hanson, M.A.,Lian, T.,Deary, A.,Patel, N.,Jacobson, K.A.,Katritch, V.,Stevens, R.C. (登録日: 2017-07-11, 公開日: 2018-02-21, 最終更新日: 2024-10-16) |
| 主引用文献 | White, K.L.,Eddy, M.T.,Gao, Z.G.,Han, G.W.,Lian, T.,Deary, A.,Patel, N.,Jacobson, K.A.,Katritch, V.,Stevens, R.C. Structural Connection between Activation Microswitch and Allosteric Sodium Site in GPCR Signaling. Structure, 26:259-269.e5, 2018 Cited by PubMed Abstract: Sodium ions are endogenous allosteric modulators of many G-protein-coupled receptors (GPCRs). Mutation of key residues in the sodium binding motif causes a striking effect on G-protein signaling. We report the crystal structures of agonist complexes for two variants in the first sodium coordination shell of the human A adenosine receptor, D52N and S91A. Both structures present an overall active-like conformation; however, the variants show key changes in the activation motif NPxxY. Changes in the hydrogen bonding network in this microswitch suggest a possible mechanism for modified G-protein signaling and enhanced thermal stability. These structures, signaling data, and thermal stability analysis with a panel of pharmacological ligands provide a basis for understanding the role of the sodium-coordinating residues on stability and G-protein signaling. Utilizing the DN variant is a promising method for stabilizing class A GPCRs to accelerate structural efforts and drug discovery. PubMed: 29395784DOI: 10.1016/j.str.2017.12.013 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.6 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






